Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Ways to protect your liver during the holidays, especially if you have hepatitis, fatty liver disease or cirrhosis.
A review of the major findings presented at the Annual Meeting of the American Association for the Study of Liver Diseases in San Francisco
A considerable proportion of a group of people receiving HIV care had signs of the disease, but only a small group was diagnosed.
Viking Therapeutics’ investigational drug is called VK2809.
Having a low CD4 count was also associated with the liver condition in a recent small study.
A look at highlights from the 2018 Liver Meeting focusing on nonalcoholic fatty liver disease.
Liver fat may be a driver of increased cancer risk associated with obesity.
NAFLD appears to have a “bidirectional” course in patients with type 2 diabetes, according to new findings.
The tool can predict whether people with fatty liver disease will develop advanced fibrosis with up to 92 percent accuracy.
Even light drinking may make NAFLD-related liver damage worse.
By balancing two enzymes that work against each other to control fat metabolism, scientists hope to help stop the disease in its tracks.
Non-alcoholic fatty liver disease can lead to cirrhosis and liver cancer.
Madrigal Pharmaceuticals is the latest company to enter into what’s becoming a crowded market.
For those with NAFLD and NASH, health care costs can more than double in just five years if screening is delayed.
The costs rise particularly steeply for those who quickly progress to end-stage liver disease.
As kids get heavier, doctors are increasingly seeing pediatric cases of fatty liver disease.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.